Ironwood Pharmaceuticals (IRWD) Payables: 2010-2025
Historic Payables for Ironwood Pharmaceuticals (IRWD) over the last 15 years, with Sep 2025 value amounting to $1.6 million.
- Ironwood Pharmaceuticals' Payables fell 50.15% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year decrease of 46.60%. This contributed to the annual value of $2.1 million for FY2024, which is 72.84% down from last year.
- According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Payables is $1.6 million, which was up 16.13% from $1.4 million recorded in Q2 2025.
- Ironwood Pharmaceuticals' Payables' 5-year high stood at $7.8 million during Q4 2023, with a 5-year trough of $118,000 in Q1 2023.
- Its 3-year average for Payables is $3.6 million, with a median of $3.2 million in 2024.
- Per our database at Business Quant, Ironwood Pharmaceuticals' Payables crashed by 79.01% in 2021 and then soared by 5,172.88% in 2024.
- Ironwood Pharmaceuticals' Payables (Quarterly) stood at $935,000 in 2021, then crashed by 48.34% to $483,000 in 2022, then spiked by 1,521.12% to $7.8 million in 2023, then slumped by 72.84% to $2.1 million in 2024, then tumbled by 50.15% to $1.6 million in 2025.
- Its Payables was $1.6 million in Q3 2025, compared to $1.4 million in Q2 2025 and $5.8 million in Q1 2025.